BIOMAT Database Logo BIOMAT Database Logo

[The mechanism of thrombocyte aggregation autoregulation]. 1973

I L Lisovskaia, and A A Markosian, and R I Volkova

UI MeSH Term Description Entries
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

I L Lisovskaia, and A A Markosian, and R I Volkova
[Mechanism of thrombocyte aggregation induced by staphylococcal toxin].
January 1987, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Mechanism of action of different inhibitors of thrombocyte aggregation].
January 1984, Vestnik Akademii meditsinskikh nauk SSSR,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Synthetic polycations as activators of the endogenous mechanism of thrombocyte aggregation].
May 1977, Biulleten' eksperimental'noi biologii i meditsiny,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
March 1979, Schweizerische medizinische Wochenschrift,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Model studies and new aspects on the mechanism of thrombocyte aggregation].
March 1969, Blut,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Thrombocyte aggregation inhibition].
August 1998, Der Internist,
I L Lisovskaia, and A A Markosian, and R I Volkova
[On the mechanism of thrombocyte aggregation. II. Increased adhesiveness through charged macromolecules].
December 1967, Thrombosis et diathesis haemorrhagica,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Inhibitors of thrombocyte aggregation].
January 1983, Farmakologiia i toksikologiia,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Thrombocyte aggregation in the cat].
August 1991, Tierarztliche Praxis,
I L Lisovskaia, and A A Markosian, and R I Volkova
[Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
February 1975, Arzneimittel-Forschung,
Copied contents to your clipboard!